Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia
Quintarelli, C., Sivori, S., Caruso, S., Carlomagno, S., Falco, M., Boffa, I., Orlando, D., Guercio, M., Abbaszadeh, Z., Sinibaldi, M., Di Cecca, S., Camera, A., Cembrola, B., Pitisci, A., Andreani, MЖурнал:
Leukemia
DOI:
10.1038/s41375-019-0613-7
Date:
November, 2019
Файл:
PDF, 1.57 MB
2019